Diabetes — all decisions

The Board denied service connection for chronic fatigue syndrome (CFS) and remanded claims for a disability manifested by shortness of breath, hypertension, diabetes mellitus, type II, and left lower neuropathy.

The Board granted service connection for diabetes mellitus, type II and hypertension based on the evidence of record at the time of the July 2025 rating decision.

The Board denied the Veteran's petitions to readjudicate claims for service connection for bradycardia, diabetes mellitus, hypertension, emphysema, hypothyroidism, polypectomy, prostate cancer, and rheumatoid arthritis as new and relevant evidence was not received. The claim for an acquired psychiatric disability is remanded.

The Board remands the claim for service connection of diabetes type 2 to obtain a medical opinion that adequately addresses whether the Veteran's diabetes is secondary to his service-connected disabilities, including obesity as an intermediate step.

The Board remands the claims for service connection for prostate cancer, diabetes mellitus type II, and diabetic neuropathy of the upper and lower extremities due to a need for clarification regarding the Veteran's exposure to Agent Orange.

The Board granted a 100 percent disability rating for PTSD and denied an earlier effective date. The claims for service connection for various conditions were remanded.

The Board granted reconsideration of the issues of entitlement to service connection for basal cell carcinoma, an acquired psychiatric disorder, and bilateral upper and lower extremity diabetic peripheral neuropathy. The claims for these conditions were previously denied but are now being readjudicated due to new evidence.

The Board granted an earlier effective date of March 11, 2024, for TDIU and assigned a 30 percent rating for expressive aphasia associated with the Veteran's stroke. Other claims were denied.

The Board denied service connection for diabetes mellitus type II and denied earlier effective dates for headaches, but granted an earlier effective date of January 12, 2012, for prostate cancer-related conditions. The decision also remanded Meniere's disease and granted special monthly compensation at the housebound rate.

The Board dismissed the appeal for service connection of diabetes mellitus, type 2 as secondary to PTSD due to a deferred decision in February 2025 that was not final.

The Board denied the Veteran's appeal for a rating in excess of 20 percent for diabetes mellitus, as the evidence did not support the need for insulin or episodes of ketoacidosis or hypoglycemic reactions requiring hospitalization.

The Board granted service connection for the cause of the Veteran's death, finding that diabetes contributed substantially to his death.

The Board remands the claims for service connection for obstructive sleep apnea, diabetes mellitus, and hypertension as secondary to PTSD, as well as the claim for a higher initial rating for right knee disability and TDIU prior to May 10, 2022.

The Board granted service connection for bilateral hearing loss, tinnitus, back disability, bilateral achilles tendonitis, gout, diabetes mellitus, type 2 (DMII), obstructive sleep apnea, and an acquired psychiatric disorder, to include anxiety and depression. The Board denied increased ratings for right and left knee degenerative joint disease, separate ratings for instability of the knees, a separate rating for residuals of a right knee meniscectomy, and service connection for bilateral leg pain, posttraumatic stress disorder (PTSD), chronic sinus disability, respiratory disability due to exposure to asbestos, heart murmur, irregular heartbeat, and seizures.

The Board remands the claims for service connection for diabetes mellitus, type I and related conditions due to a need for additional development of the record.

The Board denied a rating greater than 20 percent for diabetes mellitus, type II, with bilateral cataracts and total disability based upon individual unemployability (TDIU) as the evidence did not support an increase in the Veteran's ratings or entitlement to TDIU.

The Board remands the claims for further development, including obtaining private treatment records and scheduling VA examinations.

The Board dismissed the appeal for service connection for diabetes, glaucoma, left foot and toe tingling and numbness sensation, left hand and fingers tingling and numbness sensation, right foot and toe tingling and numbness sensation, right hand and fingers tingling and numbness sensation, and stomach cancer as moot.

The Veteran's service-connected disabilities, along with his limited education, skills, training, and work history, limit his ability to secure or follow a substantially gainful occupation. Accordingly, entitlement to a TDIU is granted.

The Board granted service connection for diabetes mellitus, type II, coronary artery disease (CAD), and bilateral upper extremity peripheral neuropathy.